alendronate has been researched along with Vascular Diseases in 3 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Neill, WC | 1 |
Toussaint, ND | 1 |
Lau, KK | 1 |
Strauss, BJ | 1 |
Polkinghorne, KR | 1 |
Kerr, PG | 1 |
Mori, K | 1 |
Shioi, A | 1 |
Jono, S | 1 |
Nishizawa, Y | 1 |
Morii, H | 1 |
1 trial available for alendronate and Vascular Diseases
Article | Year |
---|---|
Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial.
Topics: Aged; Alendronate; Aorta; Calcinosis; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle | 2010 |
2 other studies available for alendronate and Vascular Diseases
Article | Year |
---|---|
Mineral complexes and vascular calcification.
Topics: Adenine; Alendronate; alpha-Fetoproteins; Animals; Biomarkers; Calcinosis; Calcium; Chemical Precipi | 2009 |
Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification.
Topics: Alendronate; Animals; Blotting, Northern; Calcinosis; Calcium; Calcium-Binding Proteins; Cattle; Cel | 1998 |